Head of Regeneron Cell Medicines

Responsibilities

• Set the long-term scientific vision and portfolio strategy for ex vivo and in vivo cell medicines.
• Lead matrixed teams to deliver milestones from target validation through IND and early clinical development.
• Oversee technical problem-solving in areas such as CAR T design, delivery optimization, and safety risk mitigation.
• Build, mentor, and retain a high-performing organization of senior scientific leaders and functional experts.
• Partner with cross-functional departments including Clinical, Regulatory, CMC, and Manufacturing to accelerate programs.
• Identify and evaluate external innovation opportunities and manage strategic collaborations.
• Manage budgets, headcount planning, and resource allocation across the cell medicines portfolio.

Requirements

• PhD, MD, or MD/PhD in cell biology, immunology, bioengineering, or a related discipline.
• 20+ years of biopharmaceutical R&D experience with a focus on cell-based therapies.
• Proven track record of advancing programs from discovery to IND and early clinical stages.
• Deep expertise in cell engineering (e.g., CAR design, viral vectors) and in vivo gene delivery (e.g., LNPs, viral modalities).
• Strong knowledge of regulatory pathways for cell and gene therapies, including FDA/EMA guidance and IND preparation.
• Demonstrated experience leading multidisciplinary, multisite teams in a fast-paced environment.
• Exceptional communication and stakeholder management skills for executive-level engagement.

About the Company

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, the company has a unique ability to translate science into medicine, resulting in numerous FDA-approved treatments and a robust pipeline across various therapeutic areas including oncology, immunology, and rare diseases.